Silence Therapeutics plc
Silence Therapeutics plc
SLN
Valuace
70
Růst
0
Zdraví
75
Cena
$ 6.62
Dnes
--0.52 (-9.35%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-85%
ROA
-43%
PE
-3
PS
521
Cena 1R
2-8
⌀ Cena
5.46
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Silence Therapeutics plc, biotechnologická společnost, se zaměřuje na objevování a vývoj nových terapií ribonukleové kyseliny (RNA) v hematologii, kardiovaskulárních a dalších vzácných a metabolických indikacích. Platforma společnosti zahrnuje mRNAi GalNAc platformu pro zjišťování oligonukleotidů navrženou tak, aby přesně cílila na specifické geny související s onemocněním v játrech. Navrhuje krátké interferující RNA molekuly, které využívají přirozený mechanizmus interference RNA v těle, a degradující RNA molekuly, které kódují specifické cílené proteiny spojené s nemocí v buňce. Společnost vyvíjí různé přípravky, včetně SLN360, což je fáze I klinických studií pro léčbu kardiovaskulárních onemocnění s vysokým obsahem lipoproteinů; SLN124, která je ve fázi I klinických studií pro léčbu talasemie nezávislé na transfuzi a fáze I klinických studií pro léčbu myelodysplastického syndromu; a SLN124 pro léčbu polycythemie vera. Společnost uzavřela dohody o spolupráci s AstraZeneca PLC za účelem objevení, vývoje a komercializace malých interferujících RNA terapeutických přípravků pro léčbu kardiovaskulárních, ledvinových, metabolických a respiračních onemocnění; a Mallinckrodt Pharma IP Trading DAC za účelem vývoje a komercializace RNAi lékových cílů určených k umlčení kaskády komplementu při poruchách zprostředkovaných komplementem. Společnost také spolupracuje se společností Hansoh Pharmaceutical Group Company Limited na vývoji siRNAs pro tři nezveřejněné cíle využívající platformu mRNAi GOLD společnosti Silence. Společnost byla dříve známá jako SR Pharma plc a v květnu 2007 změnila svůj název na Silence Therapeutics plc. Silence Therapeutics plc sídlí v Londýně ve Spojeném království.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
116
Založení
2020-09-08
Adresa
72 Hammersmith Road
CEO
Craig A. Tooman

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues559.00559.0043,258.0025,375.0017,501.0012,415.005,479.00244.000.0016.00770.000.0015.00117.00163.00694.002,366.00
Cost of Revenues215.00215.0011,810.0010,318.0010,880.007,456.003,762.000.000.000.000.007,114.008,884.005,648.003,378.003,361.005,821.00
Gross Profit344.00344.0031,448.0015,057.006,621.004,959.001,717.00244.000.0016.00770.00-7,114.00-8,869.00-5,531.00-3,215.00-2,667.00-3,455.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues34.00159.00224.00142.0024,327.761,142.00598.0015,699.002,099.002,798.00
Cost of Revenues12.0064.0085.0054.001,606.192,774.002,638.002,800.001,346.001,607.00
Gross Profit22.0095.00139.0088.0022,721.57-1,632.00-2,040.0012,899.00753.001,191.00
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.0044,025.0035,605.0030,765.0020,209.0013,336.009,743.007,943.008,711.007,114.008,884.005,648.003,378.003,360.005,822.00
Selling General & Admin Expenses0.000.000.0020,636.0019,609.0020,008.0013,983.009,642.0010,828.006,464.003,965.002,655.003,258.003,541.002,613.002,647.005,133.00
Depreciation & Amortization525.74412.86593.00498.00708.00437.00625.00509.00399.00433.00310.00182.00332.00297.00252.00305.00323.00
Total Operating Expenses90,097.0090,097.0094,767.0064,661.0055,214.0050,773.0037,564.0022,978.0020,571.0014,407.0012,676.009,769.0012,142.009,189.005,991.002,647.005,133.00
Operating Income-87,976.68-89,753.00-63,319.00-49,604.00-48,593.00-45,814.00-35,847.00-22,734.00-20,571.00-14,391.00-11,906.00-9,769.00-12,127.00-9,072.00-26,314.00-5,786.00-8,658.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.009,937.008,934.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.004,115.004,956.00
Depreciation & Amortization83.74156.00148.00138.00119.28115.00119.00152.00121.00125.00
Total Operating Expenses12,483.0026,339.0024,102.0028,497.0025,799.9620,905.0016,283.0018,480.0014,052.0013,890.00
Operating Income-11,137.00-26,244.00-23,963.00-28,409.00-3,078.39-22,537.00-18,323.00-5,581.00-13,299.00-12,699.00
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.002,588.754,472.001,446.00226.0010.00129.0027.0045.00206.001,544.00340.00147.0070.0018.0056.0095.00
Interest Expense0.000.000.0034.0047.008.00323.00163.00-45.0015.00-1,544.00-340.00-147.00-70.00-30.0013.0063.00
Other Expense2,423.081,152.0018,855.00-706.001,225.00-42.00-194.00-136.006.0010,410.001,544.00340.00147.0070.00-20,474.0049.00-137.00
IBT-88,601.00-88,601.00-44,464.00-50,310.00-47,368.00-45,856.00-36,041.00-22,870.00-20,526.00-3,775.00-10,362.00-9,429.00-11,980.00-9,002.00-26,284.00-5,737.00-8,795.00
Income Tax Expense11.0011.00845.00-7,043.00-6,879.00-6,446.00-3,494.00-3,288.00-2,115.00-2,157.00-1,922.00-2,784.00-892.00-70.00-30.00-49.00137.00
Net Income-88,612.00-88,612.00-45,309.00-43,267.00-40,489.00-39,410.00-32,547.00-19,582.00-18,411.00-1,618.00-8,440.00-6,645.00-11,088.00-9,002.00-26,284.00-5,737.00-8,795.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.000.000.00886.95981.001,065.00804.000.002,046.00
Interest Expense0.000.000.000.00-11,544.698,602.00183.0013.00928.008.00
Other Expense-633.005,287.00-3,381.00-121.0026,814.64-7,621.00882.003,513.00-1,667.002,038.00
IBT-11,770.00-20,957.00-27,344.00-28,530.0023,736.25-30,158.00-17,441.00-2,068.00-14,966.00-10,661.00
Income Tax Expense0.001.0010.000.009,562.06-3,146.00-1,879.00244.00-554.00-2,411.00
Net Income-11,770.00-20,958.00-27,354.00-28,530.0014,174.19-27,012.00-15,562.00-2,312.00-14,412.00-8,250.00
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.17$-1.26$-1.33$-1.19$-0.78$-0.79$-0.07$-0.36$-0.31$-0.66$-0.61$-4.11$-1.84$-4.74
EPS Diluted$0.00$0.00$0.00$-1.17$-1.26$-1.33$-1.19$-0.78$-0.79$-0.07$-0.36$-0.31$-0.66$-0.61$-4.11$-1.84$-4.74
Shares Outstanding47,231.5747,231.5715,416.9137,092.4432,194.8429,650.1527,258.7925,042.2923,437.6323,314.1923,267.2121,341.3016,808.2614,642.506,389.373,112.431,855.36
Diluted Shares Outstanding47,231.5747,231.5715,416.9137,092.4232,194.8429,650.1527,258.7925,042.2923,437.6323,314.1923,267.2121,341.3016,808.2614,642.506,389.373,112.431,855.36
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.37$-0.22
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.37$-0.22
Shares Outstanding47,231.5715,744.6515,744.0115,742.0815,552.8015,688.6815,578.7714,653.4638,920.8537,305.39
Diluted Shares Outstanding47,231.5715,744.6515,744.0115,742.0815,552.8015,688.6815,578.7714,653.4638,920.8337,305.39
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents109,482.00121,330.0054,031.0054,816.0073,537.0027,449.0013,515.0021,494.0042,745.0039,012.0051,907.0016,857.0015,890.008,909.003,688.003,567.00
Short Term Investments40,112.0026,004.000.0016,328.000.0010,000.0020,001.005,043.00319.003.002.005,000.005,000.000.000.000.00
Total Cash & ST Investments149,594.00147,334.0054,031.0071,144.0073,537.0037,449.0033,516.0026,537.0043,064.0039,012.0051,907.0021,857.0020,890.008,909.003,688.003,567.00
Accounts Receivable14,538.0026,908.00228.0017,342.008,487.0032,842.003,064.002,080.002,483.002,997.001,641.00375.00390.00148.000.000.00
Inventory0.000.000.000.000.001,492.000.00-2,446.00-2,483.00-2,994.00-1,639.00-375.00-390.00-148.000.0027.00
Other Current Assets12,244.0013,124.008,157.000.000.004,616.00885.00881.002,483.002,997.001,641.00377.00392.00150.00212.00783.00
Total Current Assets176,376.00187,366.0081,021.0096,686.0086,333.0076,399.0037,465.0029,498.0045,547.0042,012.0053,550.0022,234.0021,282.009,059.003,900.004,377.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents82,031.0041,739.0064,886.00121,330.0061,953.00109,482.00142,733.0654,031.0058,812.0029,720.00
Short Term Investments20,161.0072,416.0071,648.0026,004.0067,037.0040,112.0050,118.670.000.0020,501.00
Total Cash & ST Investments102,192.00114,155.00136,534.00147,334.00128,990.00149,594.00192,851.7354,031.0058,812.0050,221.00
Accounts Receivable22,180.0020,042.0016,837.0026,908.00288.001,686.0023,772.8518,833.00462.0012,323.00
Inventory0.000.000.000.000.000.000.00-18,605.000.000.00
Other Current Assets9,260.0014,356.0016,419.0013,124.0028,234.0025,096.0012,813.108,157.0028,329.0019,770.00
Total Current Assets133,632.00148,553.00169,790.00187,366.00157,512.00176,376.00229,437.6881,021.0087,603.0082,314.00
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment1,686.001,975.001,813.002,201.001,944.001,127.00611.00921.001,170.001,375.001,093.00458.00218.00157.00225.00288.00
Goodwill7,662.009,392.007,840.008,009.007,592.008,125.007,692.008,127.008,029.007,709.006,663.007,077.007,549.007,333.0028,342.0028,346.00
Intangible Assets267.00312.00284.00320.0024.0017.0034.0064.0028.0045.006.002.00251.00526.00971.00945.00
Long-Term Investments284.000.00284.00284.00301.00303.00-19,726.00-4,768.000.004,417.000.000.000.000.000.000.00
Other Long-Term Assets2,361.003,590.002,580.000.000.000.0020,001.005,043.00233.00239.00233.000.000.000.00-3,688.00-3,566.00
Total Long-Term Assets12,260.0015,269.0012,801.0010,814.009,861.009,572.008,612.009,387.009,460.0013,782.007,995.007,537.008,018.008,016.0029,538.0029,579.00
Total Assets188,636.00202,635.0093,822.00107,500.0096,194.0085,971.0046,077.0038,885.0055,007.0055,794.0061,545.0029,771.0029,300.0017,075.0033,438.0033,956.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment1,847.001,833.001,800.001,975.001,647.001,686.002,261.141,813.001,927.002,038.00
Goodwill10,612.0010,617.009,784.009,392.007,538.007,662.009,760.387,840.007,835.007,773.00
Intangible Assets300.00317.00310.00312.00258.00267.00347.19284.00293.00302.00
Long-Term Investments0.000.000.000.00284.00284.00358.55284.00284.00284.00
Other Long-Term Assets399.003,913.003,614.003,590.002,144.002,361.003,238.312,580.000.00-10,397.00
Total Long-Term Assets13,158.0016,680.0015,508.0015,269.0011,871.0012,260.0015,965.5612,801.0010,339.0010,397.00
Total Assets146,790.00165,233.00185,298.00202,635.00169,383.00188,636.00245,403.2493,822.0097,942.0092,711.00
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable14,992.003,697.002,629.003,186.004,065.008,192.006,888.003,830.002,657.001,610.001,118.002,013.001,724.00959.001,260.001,686.00
Short-Term Debt184.00117.00179.00446.00137.00341.00287.000.000.000.000.00-1,473.00-1,248.00-854.000.000.00
Other Current Liabilities0.0011,806.0014,011.009,447.006,718.000.000.000.000.000.000.001,176.00955.00511.000.000.00
Current Liabilities17,942.0016,822.0017,769.0021,943.0015,167.0025,575.009,653.003,830.002,657.001,610.001,118.002,013.001,724.00959.001,260.001,686.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable16,993.0014,311.0018,812.003,697.0014,271.0014,992.0013,239.822,629.0011,945.0012,197.00
Short-Term Debt85.000.0060.00117.00139.00184.00232.30179.00201.00198.00
Other Current Liabilities0.000.000.0011,806.002,503.000.000.008,850.000.000.00
Current Liabilities17,379.0014,768.0019,264.0016,822.0016,913.0017,942.0017,897.1817,769.0018,017.0019,557.00
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt0.000.0093.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Capital Leases184.00117.00272.00446.00137.00341.00287.000.000.000.000.000.000.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities76,129.0068,612.0076,772.0085,428.0087,668.0076,912.0025,168.003,830.002,657.001,610.001,118.002,013.001,724.00959.001,260.001,686.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt97.000.000.000.000.000.00117.4193.00114.00166.00
Capital Leases182.000.0060.00117.00139.00184.00349.71272.00315.00364.00
Def. Tax Liability0.000.000.000.000.000.000.00-58,910.00-59,813.00-60,732.00
Total Liabilities72,727.0071,078.00298,041.0068,612.0074,868.0076,129.0088,977.1276,772.0077,944.0080,455.00
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock7,019.0010,288.005,942.005,390.004,489.004,165.003,919.003,554.003,500.003,490.003,490.002,605.002,353.001,872.005,771.002,799.00
Retained Earnings-320,150.00-474,044.00-304,612.00-263,263.00-222,966.00-184,215.00-151,999.00-133,777.00-116,428.00-115,950.00-109,435.00-102,958.00-91,870.00-82,928.00-57,772.00-53,831.00
Comprehensive Income24,055.00-11,781.0064,273.0024,333.0023,789.00189,109.00168,989.00165,278.00165,278.00166,644.00166,372.00128,111.00117,093.0097,172.00-3,082.00-3,280.00
Total Common Equity112,507.00134,023.0017,050.0022,072.008,526.009,059.0020,909.0035,055.0052,350.0054,184.0060,427.0027,758.0027,576.0016,116.0032,178.0032,270.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock10,290.0010,290.00-10,289.0010,288.007,082.007,019.008,819.825,942.005,800.005,512.00
Retained Earnings-550,802.00-529,844.00502,536.00-474,044.00-346,648.00-320,150.00-385,950.91-304,612.00-290,605.00-282,762.00
Comprehensive Income-3,073.00-1,404.008,084.00-11,781.0071,250.0068,761.0030,437.5824,199.0024,203.0024,144.00
Total Common Equity74,063.0094,155.00-112,743.00134,023.0094,515.00112,507.00156,426.1217,050.0019,998.0012,256.00
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt184.00117.00272.00446.00137.00341.00287.000.000.000.000.000.000.000.000.000.00
Book Value112,507.00134,023.0017,050.0022,072.008,526.009,059.0020,909.0035,055.0052,350.0054,184.0060,427.0027,758.0027,576.0016,116.0032,178.0032,270.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value74,063.0094,155.00-112,743.00134,023.0094,515.00112,507.00156,426.1217,050.0019,998.0012,256.00
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-46,433.00-88,612.00-36,190.11-50,310.00-47,368.00-45,856.00-36,041.00-22,870.00-20,526.00-3,775.00-10,362.00-9,429.00-11,980.00-9,002.00-26,284.00-5,786.00-8,658.00
Depreciation & Amortization485.00312.00593.00498.00482.00427.00496.00482.00399.00433.00310.00182.00332.00297.00252.00305.00323.00
Stock-Based Compensation11,889.008,074.0013,025.0513,050.0010,252.008,632.004,395.00584.00681.00638.00475.00777.001,127.001,586.00656.00121.00659.00
Change Working Capital-2,959.007,557.22-33,023.00-11,662.00-8,263.0038,845.0018,657.0021,085.00913.001,711.00-539.00-1,123.0052.00125.0012.00262.00-2,891.00
Change In Accounts Receivable10,479.003,767.82-904.00314.00-584.000.000.000.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable0.00-3,033.600.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.0027.00-28.00
Other Non-cash Items-2,044.0026,345.74-12,889.949,074.00-559.00347.00-4,670.00136.00-45.00-206.00-1,544.00-175.00119.00158.0014.001.00-2,891.00
Cash from Operations-29,047.000.000.00-39,350.00-45,456.006,806.00-10,776.001,727.00-16,760.00-9,599.00-10,066.00-8,255.00-9,458.00-6,756.00-4,876.00-5,110.00-10,552.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-82,166.22-20,958.00-27,354.00-22,084.2222,891.25-41,884.86-19,755.00-2,312.00-14,966.00-10,661.00
Depreciation & Amortization509.00156.00148.00138.00119.28115.00150.00152.00121.00125.00
Stock-Based Compensation7,274.212,535.002,085.002,740.213,422.773,096.004,141.004,118.001,505.003,852.00
Change Working Capital-3,654.765,212.00-4,502.006,746.79-26,323.95253.5410,933.00-10,323.00-1,133.003,671.00
Change In Accounts Receivable159.11-6,281.00-2,003.00727.63-2,094.161,394.145,228.00-1,226.00234.0011,861.00
Change In Accounts Payable-2,659.690.000.000.000.000.000.000.000.000.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items65,210.312,163.007,829.00150.22-24,973.6418,764.31-878.00-778.001,667.00-2,038.00
Cash from Operations0.000.000.000.000.000.000.000.00-11,866.00-4,872.00
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-88.00-55.00-211.00-45.00-440.00-1,334.00-514.00-9.00-188.00-173.00-537.00-850.00-338.00-138.00-202.00-275.00-292.00
Acquisitions0.000.000.000.000.000.0040,715.000.00-58.00-13,217.000.000.000.000.000.000.00746.00
Investments-39,441.00-166,413.00-139,167.00-20,666.00-16,125.0010,000.00-40,042.00-15,000.00-5,000.00-4,921.00-4,299.000.000.00-5,000.000.00-6.000.00
Sales of Investment20,104.000.000.0036,183.000.000.0010,000.000.00319.0018,123.000.005,000.000.000.0039.000.000.00
Other Investing Activities-38,103.000.000.00958.0023.0010.00-541.00-6.0097.0013,202.00161.00175.00137.0040.0030.0037.00105.00
Cash from Investing-17,474.000.000.0016,430.00-16,542.008,676.009,618.00-15,015.00-4,830.0013,014.00-4,675.004,325.00-201.00-5,098.00-133.00-244.00559.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-55.00-3.00-48.00-4.00-55.77-49.00-85.000.00-1.00-20.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments-166,413.000.00-2,389.00-70,060.00-21,261.83-68,022.8042.00-49,908.000.00-2.00
Sales of Investment26,558.000.00875.000.0091,430.7619,415.000.000.000.0020,104.00
Other Investing Activities0.000.000.000.000.000.000.000.00383.00546.00
Cash from Investing0.000.000.000.000.000.000.000.00382.0020,628.00
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-189.000.000.00-174.00-190.00-211.00-402.000.000.000.000.000.000.000.000.000.00-1,940.00
Debt Issued9.00117.00-155.000.00499.007.00456.00287.000.000.000.000.000.000.000.000.001,940.00
Issuance of Common Stock135,097.000.000.0025,329.0043,239.0030,922.0015,830.005,273.00341.0048.000.0039,153.0010,844.0018,784.0010,248.005,519.0014,358.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00-101.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Financing Activities15,499.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Cash from Financing128,363.000.000.0025,155.0043,049.0030,711.0015,428.005,273.00341.0048.00-101.0039,153.0010,844.0018,784.0010,248.005,519.0012,418.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.00-43.00-49.00
Debt Issued182.00182.00-60.00-57.00-22.00-45.00-165.7177.710.000.00
Issuance of Common Stock0.000.000.000.000.000.000.000.009,963.0012,081.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.000.000.00
Cash from Financing0.000.000.000.000.000.000.000.009,920.0012,032.00
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash79,762.00-81,676.9352,541.00-785.00-18,721.0046,088.0013,934.00-7,979.00-21,251.003,733.00-12,895.0035,050.00967.006,981.005,221.00121.002,436.00
Closing Cash Balance109,482.008,369.34121,330.0054,031.0054,816.0073,537.0027,449.0013,515.0021,494.0042,745.0039,012.0051,907.0016,857.0015,890.008,909.003,688.003,567.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-52,510.7940,292.00-23,147.00-56,444.0059,377.00-47,529.00-4,273.0073,934.00-4,781.0029,092.00
Closing Cash Balance8,369.3482,031.0041,739.0064,886.00121,330.0061,953.00138,450.00142,723.0054,031.0058,812.00
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-29,135.00-62,326.00-67,851.00-39,395.00-45,896.005,472.00-11,290.001,718.00-16,948.00-9,772.00-10,603.00-9,105.00-9,796.00-6,894.00-5,078.00-5,385.00-10,844.00
Real Free Cash Flow-41,024.00-70,400.00-80,876.05-52,445.00-56,148.00-3,160.00-15,685.001,134.00-17,629.00-10,410.00-11,078.00-9,882.00-10,923.00-8,480.00-5,734.00-5,506.00-11,503.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-17,342.00-10,894.00-21,832.00-12,313.00-24,920.06-19,705.00-5,494.00-9,143.00-11,867.00-4,892.00
Real Free Cash Flow-24,616.21-13,429.00-23,917.00-15,053.21-28,342.83-22,801.00-9,635.00-13,261.00-13,372.00-8,744.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-3.3-15.9-1.4
P/S521.382.49.4
P/B3.921.25.2
P/FCF-3.8-78.4-1.5
Market cap$0.3$3.7
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0.1 %0.2 %0 %
Debt to Income-0.2 %-0.5 %0 %
Debt to Free cash flow-0.2 %-9051.2 %0 %
Interest expense percentage0 %-1.4 %44.7 %
Current ratio7.7 5 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-119.6 %-129.8 %0 %
ROA-60.4 %-31.3 %0 %
CapEx to Revenue0.4 %6.1 %0 %
RaD to Revenue0 %226.5 %0 %
ROEM4,819.0 96336

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin92.7 %-23.9 %68.7 %
Operating margin-328.7 %-411.2 %35.5 %
Net margin-252.2 %-344.1 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding15.7 mil 32.3 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader